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ABSTRACT
The mouse -opioid receptor (MOR) gene has two promoters,
referred to as distal and proximal promoter. Previously, our
colleagues reported that a 26-base pair (bp) cis-acting element
of the mouse MOR gene activates MOR gene expression. Here,
we report the cloning of four members of the poly(C) binding
protein (PCBP) family and show that the 26-bp polypyrimidine
stretch in MOR proximal promoter interacts with these PCBPs
and activates MOR transcription. The PCBPs bind not only to
single-stranded but also to double-stranded DNA. The nuclear
run-off assay and semiquantitative RT-PCR shows that PCBPs
enhance the transcription rate of MOR gene. Furthermore, we
performed refined mapping to elucidate the core region (317/
304) involved in mediating the PCBP-induced MOR promoter
activity. Decoy oligonucleotides against the polypyrimidine
stretch inhibit the PCBP-induced MOR promoter activity,
thereby reconfirming the role of this element in regulating MOR
promoter activity. Chromatin immunoprecipitation assay con-
firmed the interaction of PCBPs with MOR promoter in vivo. In
conclusion, we demonstrate that PCBPs act as a transcription
factor and positively regulate MOR gene expression in NMB
cells.
Opioids exert their pharmacological and physiological ef-
fects through binding to their endogenous receptors. There
are at least three major types of opioid receptors: , , and 
(Kieffer, 1995). These receptors belong to the superfamily of
G protein-coupled receptors. Expression of opioid receptors is
mainly limited to the central nervous system, and each re-
ceptor type has a distinct distribution pattern (Bausch et al.,
1995; Minami and Satoh, 1995). These receptors regulate
responses to pain, stress, and emotions when being activated
by structurally related endogenous opioid peptides. The
-opioid receptor (MOR) is of particular interest because it is
the receptor that mediates important opioid effects such as
analgesia and addiction (Chaillet et al., 1984). The mouse
knockout studies have also concluded MOR to be the main
opioid receptor involved in analgesia (Kieffer, 1999).
Ever since the cloning of the -opioid receptor (Chen et al.,
1993; Thompson et al., 1993; Wang et al., 1993), several
laboratories, including ours, have been working toward un-
derstanding the MOR gene regulation. The MOR gene uses
two TATA-less promoters: the distal and proximal promoters,
both of which are approximately 500 bp apart and are located
within 1 kb of the translation start site. Recently, another
promoter was reported that is located approximately 10 kb
upstream to these dual promoters (Pan, 2002). The proximal
promoter is used preferentially, accounting for approxi-
mately 95% of total MOR transcripts (Ko et al., 1997). Tran-
scription of MOR from the distal promoter starts at 794 bp
upstream of the translation start site (Liang et al., 1995);
however multiple transcription sites located between 268
and 291 bp upstream to the start codon have been observed
for proximal promoter (Min et al., 1994). The proximal pro-
moter is regulated by several cis-elements and trans-acting
factors, including a neuron-restrictive silencer element (Kim
et al., 2004), an activator protein-2–like element (Ko et al.,
2003), and canonical Sp binding sites (Ko et al., 1998). Re-
cently, we reported a 26-bp polypyrimidine-rich cis-element
in the MOR proximal promoter located at 334/308, very
close to the transcription initiation sites (Ko and Loh, 2001).
This stretch of pyrimidine-rich bases is able to form a single-
stranded DNA-like structure and can bind to single-strand
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nucleic acid binding proteins. Later, we identified the inter-
acting protein with the polypyrimidine rich element to be a
poly(C) binding protein (PCBP) (Ko and Loh, 2005).
PCBPs belong to a family of RNA-binding proteins that are
characterized by high-affinity and sequence-specific interac-
tion with poly r(C). These PCBPs have been divided into two
sets in mammalian cells: hnRNP K/J (Matunis et al., 1992)
and the CP proteins (-complex proteins). The widely stud-
ied PCBPs are hnRNP K, CP-1, and CP-2. The latter two
proteins are also known as PCBP1 and PCBP2 or hnRNP E1
and hnRNP E2, respectively (Kiledjian et al., 1995; Leffers et
al., 1995). Recently, two other members of the PCBP family
were discovered and named PCBP3 and PCBP4 (Makeyev
and Liebhaber, 2000). All members of the PCBP family are
evolutionary related, and the common feature of all PCBPs is
the presence of three hnRNP K homology domains: two of
them located at the N terminus, and a third located at the
C-end (Makeyev and Liebhaber, 2002). The hnRNP K homol-
ogy domains are approximately 70 amino acid-long RNA
binding modules; however, they do not provide binding spec-
ificity to poly(C) (Dejgaard and Leffers, 1996). Members of
this PCBP family are involved in multiple functions through
their poly(C) binding nature. They can act as the mRNA
stabilizer through interaction with 5-untranslated region
(Weiss and Liebhaber, 1995; Holcik and Liebhaber, 1997) or
a translational silencer by binding to 3-untranslated region
(Ostareck et al., 1997; Collier et al., 1998).
In this study, we investigated the interaction of PCBPs
with the polypyrimidine tract in MOR proximal promoter
region and the role of PCBPs in regulating MOR gene ex-
pression in human neuroblastoma NMB cells. We showed
that PCBPs bound to the 317/304 region in MOR proxi-
mal promoter. PCBPs could also bind to double-stranded
DNA sequence. More importantly, we found PCBPs could
enhance transcription of MOR gene in nuclear runoff expe-
riences. The overexpression of PCBPs resulted in an increase
of endogenous MOR expression as well as nascent MOR
mRNA synthesis. We concluded that PCBPs act as the tran-
scription activator in regulating MOR gene expression in
NMB cells.
Materials and Methods
Cell Culture. Human neuroblastoma NMB cells were grown in
RPMI 1640 medium supplemented with 10% heat-inactivated fetal
calf serum (Invitrogen, Carlsbad, CA) in a humidified atmosphere of
5% CO2 at 37°C.
Cloning of PCBP Family. Total RNA was isolated from mouse
brain. The isolated RNA was treated with RNase-free DNase (Pro-
mega, Madison, WI), according to the manufacturer’s instructions.
RT-PCR was performed using OneStep RT-PCR kit (QIAGEN, Valencia,
CA). PCR was performed with the primers (for PCBP1: forward, 5-GAAT-
TCATGGACGCCGGTGTG-3, and reverse, 5-CTCGAGCTAGCTGCAC-
CCCAT-3; for PCBP2: forward, 5-GAATTCATGGACACCGGTGTG-3,
and reverse, 5-CTCGAGCTAGCTGCTCCCCAT-3; for PCBP3: forward,
5-GAATTCATGGAATCTAAGGTCTCG-3, and reverse, 5-CTCGAGT-
TAGAGTACACCCATCCC-3; and for PCBP4: forward, 5-GAATTCAT-
GAGCAGTTCAGATGCG-3, and reverse, 5-CTCGAGTCAGTAGGGG-
GAGAATTT-3); PCR conditions used were 94°C for 15 min; 35 cycles of
94°C for 1 min, 50°C for 1 min, and 72°C for 1 min; and 72°C for 10 min.
The primers were designed using GenBank. The RT-PCR product (approx-
imately 1000 bp) was excised from a 2% agarose gel, purified using Qia-
Quick gel extraction kit (QIAGEN), and cloned in pCRII-TOPO vector
(Invitrogen). Candidate plasmids containing the correctly sized inserts
were confirmed by restriction digestions and dideoxy sequencing on an ABI
3100 sequencer (Applied Biosystems, Foster City, CA). For transient ex-
pression studies, the PCBPs were cloned in pcDNA3.1 vector (Invitrogen).
RT-PCR of MOR Gene. Total RNA was isolated using TRI re-
agent according to the manufacturer’s instructions (Molecular Re-
search Center. Cincinnati, OH). Primers used for MOR PCR were
5-GATCATGGCCCTCTACTCCA-3 (located at position 216 in exon
1) and 5-GCATTTCGGGGAGTACGGAA-3 (located at position 557
in exon 2). Selection of primers from two different exons helped to
avoid the amplification of genomic DNA. Primers used to amplify
human -actin were 5-GCCAACACAGTGCTGTCTGG-3 and 5-
TACTCCTGCTTGCTGATCCA-3. RT-PCR was performed using
Qiagen OneStep RT-PCR Kit on GeneAmp PCR System 9600
(PerkinElmer Life and Analytical Sciences, Boston, MA). The PCR
products were electrophoresed in a 2% agarose gel and quantified by
ImageQuant 5.2 (Amersham Biosciences Inc., Piscataway, NJ).
Plasmid Construction for Reporter Assays. Luciferase fusion
plasmids were constructed containing the DNA sequence from 450
bp upstream of the mouse MOR gene (pGL-450 construct; 450 to
1 bp related to the translation start site as 1) to various lengths
of 3-short downstream regulatory sequences. The 3-deletion con-
struct, pGL-301, was generated by PCR with the upstream primer at
450 bp bearing a SacI site and the downstream primers bearing a
HindIII site. The PCR fragment was cloned into pGL3-Basic
(Promega), and the sequence of the insert was verified by DNA
sequencing.
Transient Transfection and Reporter Gene Assay. NMB
cells were plated in six-well plates at a concentration of 1  106
cells/well and cultured overnight before transfection. Each plasmid
at equimolar concentrations was transfected in NMB cells with Ef-
fectene transfection reagent (QIAGEN) according to manufacturer’s
instructions. In brief, for luciferase analysis of MOR promoter activ-
ity, 0.5 g of the reporter plasmids was mixed and incubated with
the Effectene transfection reagent for 15 min at room temperature
before being added to NMB cells. Twenty-four hours after transfec-
tion, cells were washed once with 1 phosphate-buffered saline and
lysed with reporter lysis buffer (Promega). To correct for the differ-
ences in transfection efficiency, a one-fifth molar ratio of pCH110
(Amersham Biosciences) containing the -galactosidase gene under
the simian virus 40 promoter was added in each well. The luciferase
and -galactosidase activities of each lysate were measured using
assays kits as described by the manufacturer (Promega).
In Vitro Translation. In vitro translation was carried out with
pcDNA3.1-PCBP family in a reaction mixture containing [35S]methi-
onine (Amersham Biosciences) using a TNT quick-coupled transcrip-
tion/translation system (Promega). The labeled proteins were then
electrophoresed in 12% SDS-PAGE, and their sizes were compared
with the predicted sizes (data not shown).
Nuclear Runoff Transcription. Effect of PCBPs on MOR tran-
scription was checked by nuclear runoff assay as per standard pro-
tocol (Greenberg and Bender, 2002). PCBP1, PCBP2, PCBP3, and
PCBP4 were individually transfected in NMB cells using Effectene
transfection reagent (QIAGEN) according to manufacturer’s instruc-
tions, and the nuclei were prepared after 24 h. Transcription was
allowed to proceed for 30 min at 30°C in presence of [32P]UTP and
the endogenous DNA, and protein were removed by treating with
DNase I followed by proteinase K. Runoff RNA products were puri-
fied by TRI reagent (Molecular Research Center) followed by ethanol
precipitation and were resuspended in Ambion Ultrasensitive hy-
bridization buffer (5  105 cpm/ml; Ambion, Austin, TX). RNA was
hybridized at 42°C for 72 h to linearize and denature MOR (full-
length plasmid DNA) or -actin (PCR product) probes slot-blotted on
Hybond-NX nylon membrane (Amersham Biosciences) using a slot-
blot apparatus (Schleicher & Schuell, Keene, NH). Signal intensities
were quantified using a PhosphorImager (Storm 860; Amersham
Biosciences), and the MOR signal was normalized to -actin.
Electrophoretic Mobility Shift Assay. The oligonucleotides
were end-labeled with [-32P]ATP with T4 polynucleotide kinase. To
730 Kim et al.
check the interaction of PCBPs with double-stranded DNA, the com-
plementary strands of the oligonucleotides were annealed and la-
beled with T4 polynucleotide kinase. The end-labeled DNA probes
were incubated with TNT reaction products of PCBP expression
constructs in a final volume of 20 l of electrophoretic mobility shift
assay (EMSA) buffer [10 mM Tris, pH 7.5, 5% glycerol, 1 mM EDTA,
50 mM NaCl, 1 mM dithiothreitol, and 0.1 mg/ml poly(dI-dC)] at
room temperature for 20 min. For oligonucleotide competition anal-
ysis, a 100-fold molar excess of cold competitor oligonucleotide was
added to the mixture before adding the probe. The reaction mixtures
were electrophoresed in a 4% polyacrylamide nondenaturing gel in
0.5  Tris borate-EDTA (45 mM Tris-borate and 1 mM EDTA) at
4°C, and the gel was dried. Gel was exposed to a filmless autoradio-
graphic analysis screen and scanned on a PhosphorImager.
Chromatin Immunoprecipitation Assay. NMB cells tran-
siently transfected with HA-tagged PCBP were used for chromatin
immunoprecipitation (ChIP) assay using the protocol from Upstate
Biotechnology (Lake Placid, NY). Twenty-four hours after transfec-
tion of NMB cells with Effectene transfection reagent (QIAGEN),
chromatin was cross-linked by the addition of formaldehyde to the
culture medium at a final concentration of 1% and incubated for 10
min at 37°C. Cells were washed twice with phosphate-buffered saline
containing protease inhibitor cocktail (Roche Diagnostics, Indianap-
olis, IN). Washed cells were counted, and 1  106 cells were
resuspended in 200 l of SDS lysis buffer (Zhang and Dufau, 2002).
We determined conditions to produce sheared chromatin of average
lengths between 0.5 and 1.5 kb using a cell destructor (Ultrasonic
Inc., Plainview, NY). Each sample was sonicated using the cell de-
structor at 30% intensity for six 10-s bursts with a gap of 30 s
between each burst. Cells were maintained on ice throughout.
Sheared chromatin was centrifuged for 10 min at 14,000g at 4°C,
after which the supernatant was diluted 10-fold with dilution buffer
(Zhang and Dufau, 2002). As input control, 1% of each diluted su-
pernatant was retained at this step. Chromatin was precleared for
1 h at 4°C with 75 l of 50% protein G agarose (Invitrogen), 20 g of
sonicated and sheared salmon sperm DNA, and 50 g of bovine
serum albumin. Anti-HA antibodies (2 g) (Roche) were added to
precleared supernatant, and the immunoprecipitates were allowed
to form overnight at 4°C with end-over-end rocking. Immune com-
plexes were incubated for 1 h at 4°C with 60 l of 50% protein G
agarose beads and 4 g of sonicated and sheared salmon sperm DNA
and then centrifuged gently for 1 min at 4°C. Beads were washed
four times for 5 min and eluted twice in 250 l of fresh elution buffer
(1% SDS and 0.1 M NaHCO3). Samples were heated at 65°C for 4 h
to reverse cross-links, and the DNA samples were purified by phenol/
chloroform extraction followed by ethanol precipitation. The purified
DNA was resuspended in 50 l of H2O. PCR reaction mixture con-
tained 2 l of the DNA template with the MOR-specific primers
(forward, 5-CCAACCCTTCTCTCCATCTC-3; reverse, 5-TATAGC-
CCCCTCCCACCTTA-3) spanning the human MOR promoter region
in a total volume of 20 l. After 35 cycles of amplification, 5 l of the
PCR product was analyzed on a 2% agarose gel.
Decoy Oligonucleotide Approach in NMB Cells. In the decoy
oligonucleotide approach, double-stranded oligonucleotides with spe-
cific binding sequences for transcription factors (PCBPs) were trans-
fected into cells to selectively disrupt the function of these binding
factors. In this case, transcription factors interact with an excess of
decoy oligonucleotides instead of binding to the natural regulatory
motifs of genes (Bielinska et al., 1990; Kraus et al., 2003). The
various concentrations of decoy oligonucleotides were directly co-
transfected with either PCBP-expressing constructs or the carrier
DNA (the promoterless cloning vector pGL-301). There was no chem-
ical modification on oligonucleotides. To avoid any effect on trans-
fection efficiency caused by different amounts of transfected DNA,
the total amounts of both plasmid DNA and oligonucleotides were
kept constant in the individual experiments. A nonspecific oligonucleotide
(5-ATTGCGCTCCTCCTTCTCTCTGATCGGGGCGGGGCAAGCTTAT-
A-3) was used as the negative control.
siRNA-Mediated Inhibition of PCBPs. To confirm the role of
PCBPs in MOR regulation, we used siRNAs to inhibit the expression
of PCBPs and see its effect on MOR expression level. One hundred
nanomoles of siRNA duplexes (Dharmacon Research, Lafayette,
CO: PCBP1, 5-GAAAGUGGACUAAAUGUGAUU-3; PCBP2, 5-
GAUUGAAGGUGGAUUAAAUUU-3; PCBP3, 5-GAUCUAAU-
AGGCUGCAU-AAUU-3; and PCBP4, 5-CGCCAGAUCUGCG-
CUGUUAUU-3) were transfected into NMB cells using RNAiFect
(QIAGEN) according to manufacturer’s protocol. Mock transfec-
tion was performed with transfection reagent alone. RNA was
isolated after 48 h, and the expression level of PCBP and MOR
was checked by semiquantitative RT-PCR. The primers used for
amplifying the PCBPs included the region corresponding to the
siRNA sequence (PCBP1 forward, 5-GGATGCCGGTGTGACT-
GAAAG-3; reverse, 5-TTACACCCGCCTTTCCCAATC-3; PCBP2
forward, 5-GAACACTGCTCGACATGGACAC3; reverse, 5-TCT-
CCTCGCGCAT-CTTCTTAAC-3; PCBP3 forward, 5-ACACTC-
CTCCGAAGAA-GCTC-3; reverse, 5-GGCGTTGATGAGATACT-
GGGC-3; and PCBP4 forward, 5-GGCTGGCACCAAGATCAA-
G-3; reverse, 5-GGGGACCGCATGGCTTGAG-3). The MOR-
specific primers used to check the MOR level were forward, 5-
GATCATGGCCCTCTACTCCA-3, and reverse, 5-GCATT-
TCGGGGAGTACGGAA-3. -Actin was used as the internal
control in RT-PCR.
Results
Cloning of Poly(C) Binding Protein Family. Previ-
ously, we reported a 26-bp single-stranded cis-element (poly-
pyrimidine tract) in mouse MOR proximal promoter interacts
with a polypyrimidine binding protein and regulates the
MOR gene expression (Ko and Loh, 2001). Later, by screen-
ing the mouse brain library, the polypyrimidine binding pro-
tein was identified as poly(C) binding protein. In this study,
we investigated the role of PCBPs in regulating MOR tran-
scription in human neuroblastoma NMB cells, a cell model
that expresses endogenous MOR.
First, we cloned the PCBP family members. Full-length
PCBPs were amplified using RT-PCR from mouse brain
mRNA. Specific pairs of primers (see Materials and Methods)
were used to amplify each of the PCBPs. PCR products were
cloned into pCRII-TOPO (Invitrogen). The resulting clones
were sequenced to ensure that the entire DNA sequences
were identical with that of the mouse PCBPs in the database.
For the transient transfection and expression studies, we
digested the above clones with EcoRI-XhoI to purify the full-
length coding region of PCBPs and ligated into expression
vector pcDNA3.1 at the corresponding restriction enzyme
sites. The expression pattern of all four PCBPs was exam-
ined. The PCBP family was transcribed and translated in
vitro using TNT kit (Promega) with [35S]methionine, and the
products were electrophoresed on a 12% SDS-PAGE. On the
basis of the size comparison with the molecular weight mark-
ers, the molecular weight of the translated PCBP family was
found to be approximately similar to the predicted molecular
weight deduced from the full-length cDNA sequence (data
not shown).
PCBP Family Proteins Bind to the MOR Proximal
Promoter In Vitro. To verify the binding of PCBPs to
the polypyrimidine stretch in MOR proximal promoter,
we performed EMSA with single-stranded (SS) and double-
stranded (DS) 26 nt long oligonucleotide sequence (Fig. 1A).
The 26 nt long oligonucleotide containing the PCBP bind-
ing sequence (5-TCTCTCCTCCCTCCCCTCTAGCCCTC-3;
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326 to 301) was used as the probe, and PCBP proteins
were translated in vitro using TNT kit. The binding assay
was done at room temperature for 20 min, and the products
were electrophoresed on a 4% nondenaturing PAGE. As
shown in Fig. 1B, a specific protein-probe complex band was
observed with PCBP1. A 100-fold molar excess of unlabeled
DS or SS oligonucleotide completely inhibited the complex
formation. There was no complex formation in the absence of
the translated protein product (probe only). With DS oligo-
nucleotides also, the PCBP1-DNA complex was evident, al-
though the binding efficiency was much lower compared with
the SS DNA oligonucleotides.
EMSA with other PCBP family members (PCBP2, PCBP3,
and PCBP4) and the above probe yielded results similar to
those observed with PCBP1 (Fig. 1C). These results clearly
demonstrate that PCBPs bind to the MOR proximal pro-
moter region and bind to DS as well as SS DNA in vitro.
Specific Binding of PCBP Family Proteins to the
MOR Promoter in Vivo. To support the EMSA findings
that PCBPs interact with the MOR proximal promoter region
in vitro, we performed the ChIP assay to test weather the
PCBP protein interacts with the MOR promoter in vivo.
NMB cells were transiently transfected with HA-tagged
PCBP expression construct. As shown in Fig. 2, a specific
217-bp ChIP-PCR product was detected with the specific
primer in HA-tagged PCBP–transfected cells when the sam-
ples were immunoprecipitated using anti-HA antibodies but
not in samples immunoprecipitated with preimmune serum
or anti-Flag antibodies. The result suggests that the PCBP
specifically binds to the region containing the polypyrimidine
tract in the MOR promoter in NMB cells.
PCBPs Act as Transcription Factor and Induce the
Expression of Endogenous MOR. Earlier experiments
suggested that PCBPs bind to the MOR proximal promoter
region, thereby inducing the proximal promoter activity in
reporter assays. Our next aim was to determine the role of
PCBPs in regulating endogenous MOR expression in NMB
cells. We transfected each expression construct of PCBP fam-
ily or vector (pcDNA3.1) alone into the human NMB neuro-
blastoma cells. Twenty-four hours after transfection, the to-
tal RNA was isolated, and RT-PCR was done to determine
the MOR mRNA level using a pair of MOR-specific primer.
As shown in Fig. 3A, endogenous MOR mRNA expression
increases significantly in PCBP-transfected cells. All four
members of the PCBP family were able to induce the MOR
expression by 2.5- to 4.5-fold.
To convincingly show that PCBPs can directly enhance the
rate of transcription of MOR gene, a nuclear runoff in vitro
Fig. 1. Analysis of PCBPs binding to the proximal promoter region in
vitro. A, single-stranded and double-stranded sequence was used as a
probe in EMSA analysis. EMSA was performed using 32P-labeled 26 nt
long SS or DS sequence in polypyrimidine residues from MOR proximal
promoter as a probe. B, EMSA of PCBP1 protein with SS and DS probes.
The in vitro translated PCBP1 was incubated with probe. The protein/SS
or protein/DS complex was shown. A 100-fold molar excess of competitor
oligonucleotide was added to the mixture before adding the probe. Non-
specific oligonucleotide (5-ATTGCGCTCCTCCTTCTCTCTGATCGG-
GGCGGGGCAAGCTTATA-3) was used as the negative control. C,
EMSA of PCBP2, PCBP3, and PCBP4 proteins with SS and DS probes.
The in vitro translated PCBP2, PCBP3, and PCBP4 were also incubated
with SS- or DS-labeled probe; the DNA/probe complexes formed are
shown.
Fig. 2. Analysis of PCBPs binding to the proximal promoter region in
vivo. ChIP assay was performed in NMB cells using HA-tagged PCBP.
Lysates from PCBP-transfected cells were immunoprecipitated with an-
ti-HA monoclonal antibody, nonspecific antibodies (anti-Flag or preim-
mune serum), and the bound DNA was analyzed by PCR using primers
that amplified a 217-bp region of the MOR promoter spanning the PCBP
binding site. Lane 1, 100-bp DNA marker; lane 2, input; lane 3, preim-
mune serum; lane 4, anti-Flag; lane 5, anti-HA. -Actin was used as the
negative control. The band intensity in lanes 2 to 4 was analyzed using
ImageQuant 5.2 software.
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transcription assay was performed. We transfected each of
the PCBPs in neuroblastoma NMB cells and determined the
rate of nascent MOR mRNA transcripts. The nascent mRNA
transcripts elongated in the isolated nuclei were labeled with
[-32P]UTP and hybridized to MOR or actin-specific probes.
Our results showed that overexpression of PCBPs causes a
significant increase in nascent MOR mRNA synthesis (2- to
4-fold compared with vector-transfected control), whereas
the rate of -actin mRNA synthesis remains largely un-
changed (Fig. 3B). These results suggest that PCBPs act as a
transcriptional factor and enhance the transcription rate of
MOR.
Effect of PCBP Family on MOR Proximal Promoter
Activity. To determine the function of the PCBP family on
MOR gene expression, we checked the proximal promoter
activity by cotransfection. Cotransfection was performed
using each type of PCBP expression construct and the
reporter construct containing the proximal promoter re-
gion (450/1) fused to the luciferase gene in NMB human
neuroblastoma cells. The MOR promoter activity in PCBP-
cotransfected cells was increased (approximately 5-fold)
compared with vector (pcDNA3.1)-only transfected control
cells (arbitrarily defined as 1-fold) (Fig. 4). These findings
suggest that all four PCBP family members can directly
activate the MOR proximal promoter activity at a varying
rate.
Identification of the Region Required for PCBP-
Mediated MOR Promoter Activation. The EMSA re-
sults showed the binding of PCBPs to the 326/301
region of mouse MOR promoter. To do more refined map-
ping of the region essential for PCBP-mediated MOR prox-
imal promoter activation, we mutated the 26 nucleotides at
the 3-end in pGL-301 as shown in Fig. 5. pGL-301 con-
tains the 450/301 region of MOR proximal promoter.
We simply replaced triple nucleotide sequences step by
step and cotransfected with PCBP-expressing construct in
NMB cells. The mutant constructs pGL-301-M2, pGL-301-
M3, pGL-301-M4, and pGL-301-M5 displayed 30% pro-
moter activities compared with the wild-type construct
(pGL-301-wild) (data not shown). On the other hand, mu-
tant constructs including pGL-301-M1, pGL-301-M6, pGL-
301-M7, and pGL-301-M8 displayed promoter activity
comparable with pGL-301-wild (Fig. 5). Therefore, this
result suggests that the core site required for PCBP-medi-
ated MOR promoter activation resides in the region from
317/304.
Use of Decoys to Inhibit the PCBP-Mediated Induc-
tion of Proximal Promoter Activity. We also used a decoy
oligonucleotide approach to confirm the PCBPs binding spe-
Fig. 3. PCBP family acts as a transcription factor in inducing the expres-
sion of MOR gene in NMB cells. A, endogenous MOR mRNA level of
PCBP-transfected cells using RT-PCR. NMB cells were transfected with
PCBP-expressing constructs, and the expression level of MOR was deter-
mined by RT-PCR. -Actin was used as a control. B, PCBP-transfected
cells were used for nuclear runoff assay. NMB cells were transfected with
PCBPs or pcDNA3.1 (control), and the nuclei were isolated after 24 h. The
rate of nascent mRNA synthesis was determined by in vitro transcription
in the presence of [32P]UTP and by hybridizing the nascent mRNA to the
MOR or actin-DNA blotted on a nylon membrane. Fold increase in MOR
transcription compared with the control was plotted. The results are a
representation of three independent experiments.
Fig. 4. PCBP enhances the proximal promoter activity of  opioid recep-
tor gene. A, schematic diagram of mouse MOR proximal promoter region.
Nucleotide 1 corresponds to the translation start site (ATG). TIS, tran-
scription initiation site. B, promoter activity assay of PCBP-transfected
cells. PCBP-expressing constructs were cotransfected in NMB cells and
with pGL-450 in NMB cells, and the luciferase activity was measured.
Relative activity was calculated by comparing with pGL-450 alone. The
results from at least three representative experiments were averaged.
The promoter activity was normalized by -galactosidase.
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cifically to the polypyrimidine tract in MOR promoter. For
this purpose, a luciferase reporter gene construct under MOR
promoter fragment containing PCBP binding region was co-
transfected with various concentrations of decoy oligonucle-
otide in NMB cells. The decoy oligonucleotide binds to the
PCBPs and decreases the ability of PCBPs to bind to their
cellular target sequences. Hence, decoy-induced inhibition of
PCBP-mediated induction of promoter activity was measured
(Fig. 6A). The decoy oligonucleotide was able to block the
PCBP-induced MOR promoter activity by approximately
80%. The specific interaction of PCBP family protein with the
decoy molecule is shown in Fig. 6B. The cotransfection of
MOR promoter reporter construct with mutated decoy oligo-
nucleotide did not inhibit PCBP-mediated induction of MOR
proximal promoter activity. Wild-type PCBP binding site de-
coy oligonucleotides were much more effective competitors
than the mutated decoys for inhibiting PCBP-induced MOR
promoter activation. Thus, from these results, it was con-
firmed that PCBPs binds to a specific region of MOR proxi-
mal promoter region (326/301).
siRNA-Mediated Inhibition of PCBP Expression.
Our data showed that PCBPs bind directly to the MOR
proximal promoter region and increase transcription activ-
ity. siRNAs have been used extensively to study or confirm
the gene function in the mammalian system. We used
duplex siRNAs against PCBPs individually and in combi-
nation to inhibit the expression of PCBP family and stud-
ied their effects on MOR gene expression. There was no
effect on the MOR expression level when the cells were
transfected with siRNA against one type of PCBP (Fig.
7B), even though the expression of that particular type of
PCBP was decreased (Fig. 7A), indicating a redundancy in
PCBP functions. Only the inhibition of all PCBP expres-
sion by siRNA treatment caused a decrease in MOR mRNA
level (Fig. 7B).
Our results indicate that multiplexing of siRNAs for all
four PCBPs causes significant inhibition of MOR mRNA lev-
els as evidenced by RT-PCR (Fig. 7), indicating that perhaps
all PCBPs may mainly contribute to the regulation of MOR
gene expression in NMB cells.
Discussion
Our group reported previously that a 26-nt cis-element rich
in polypyrimidine residues in MOR proximal promoter can
adopt SS DNA structure and interact with the nuclear pro-
teins. In this study, we demonstrated that this polypyrimi-
dine tract interacted with a family of PCBPs (Ko and Loh,
2005). Despite their recognized function as RNA binding
proteins, PCBPs seemed to also function to directly activate
gene transcription of the MOR gene.
The proximal promoter of the mouse MOR gene is known to
be regulated by various cis-elements and trans-factors, and
all of these elements are important in regulating proximal
promoter activities. These features are unique in the proxi-
Fig. 5. Identification of essential PCBP-binding site The mutated sequences in mutant constructs from pGL-301-M1 to pGL-301-M8 are shown in
boldface letters. The luciferase activity of the mutant constructs in NMB cells was measured as described under Materials and Methods and is
expressed as a luciferase/-galactosidase activity ratio. The proximal activity of each construct was expressed as N-fold activation of vector-only cells.
Histograms represent mean values of three independent transfection experiments with two different plasmid preparations.
Fig. 6. Decoy oligonucleotides corresponding to PCBP binding element
inhibit proximal promoter activity. NMB cells were cotransfected with
pGL-301 and PCBP-expressing constructs in the presence of wild-type or
mutant decoy oligonucleotides. A, wild-type decoy oligonucleotide atten-
uated PCBP-induced activity (reported as the percentage of decrease) of
a reporter gene construct containing a PCBP binding site in NMB cells. B,
the reporter construct was cotransfected with wild or mutant decoy
oligonucleotides (80 nM), and the effect on PCBP-induced luciferase ac-
tivity was measured. The results shown were from at least two indepen-
dent transfection experiments performed in triplicate.
734 Kim et al.
mal promoter of mouse MOR compared with the promoter of
other opioid receptor genes ( and ä). Thus, the proximal
promoter regulation of mouse MOR gene is under a fine and
tight control (Law et al., 2000; Ko and Loh, 2001; Kraus et al.,
2001; Ko et al., 2003). The 340/301 region in MOR prox-
imal promoter is rich in pyrimidine residues, especially the
cytosines. PCBPs belong to a family of nucleic acid binding
proteins that interact with poly(C) sequences with high af-
finity and specificity (Makeyev and Liebhaber, 2002). Be-
cause there is no mouse neuronal cell line endogenously
expressing MOR available so far, we performed all of our
studies in a human neuroblastoma cell line NMB, which
expresses MOR endogenously.
PCBPs have been involved in a spectrum of post-transcrip-
tional controls. First insights into the functions were ob-
tained from an investigation of human -globin mRNA sta-
bilization (Weiss and Liebhaber, 1995). Stabilization of
-globin mRNA is tightly linked to the formation of a binary
complex between a single molecule of PCBPs and pyrimidine-
rich region within the -globin. We performed a nuclear
runoff assay in PCBP-transfected NMB cells and determined
the nascent mRNA synthesized with MOR probe. MOR nas-
cent mRNA synthesis increased (2.5- to 4-fold), indicating
that PCBPs enhance MOR gene transcription. This result
provides direct evidence that PCBP can act as a transcription
factor that binds to MOR proximal promoter and thereby
enhances MOR gene transcription. Further supports were
obtained from more functional studies discussed as follows
below.
Decoy oligonucleotide studies showed that decoy oligonu-
cleotides inhibited the PCBP-induced MOR promoter activ-
ity. Mutations in decoy oligonucleotides (pGL-301-M3 and
-M4) resulted in the loss of their ability to inhibit the MOR
promoter activity. Inhibition of expression of PCBPs by
siRNA treatment caused a decrease in MOR mRNA level
when the siRNA against all four PCBPs was multiplexed.
There was not much effect on the MOR expression level when
the cells were transfected with siRNA against one type of
PCBP, even though the expression of that particular type of
PCBP was decreased, indicating a redundancy in PCBP func-
tions.
The functions of the PCBPs are mediated through its
poly(C) binding nature. There should be other factor(s) that
provide the specificity for a particular type of function to the
PCBPs. The topology of the poly(C) element and the struc-
ture of the particular PCBP might be involved in providing
the specific function. Another possibility is the involvement
of additional proteins that could facilitate the interaction
(directly or indirectly) of PCBPs with the poly(C) element in
MOR promoter. hnRNPK, a well-studied poly(C) binding pro-
tein, was shown to interact directly with TATA binding pro-
tein, a component of RNA polymerase complex (Michelotti et
al., 1995). In a recent study using PCBP2, it was shown that
PCBP2 can interact with 160 different types of mRNA and
regulate a number of cellular processes (Waggoner and Lieb-
haber, 2003).
In summary, we conclude that the PCBP family regulates
endogenous mouse MOR gene expression by acting as a tran-
scriptional activator. Further studies are required to under-
stand the actual mechanism by which PCBPs interact with
the proximal promoter and regulate the expression of the
MOR gene. Studying the interaction of PCBPs with the RNA
polymerase II and other components of the transcription
complexes may shed more light on the mechanism of MOR
gene regulation.
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